ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
|
|
|
- Harriet Rodgers
- 6 years ago
- Views:
Transcription
1 ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3 Personal history of malignant neoplasm of V10.41: Personal history of malignant Z85.41 Personal history of malignant neoplasm of cervix uteri V13.22: Personal history of cervical Z Personal history of cervical dysplasia dysplasia V16.3: Family history of malignant Z83.0 Family history of malignant neoplasm of neoplasm of V67.01: Follow-up vaginal pap smear Z01.42 Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear Z08 Z09 Encounter for follow-up examination after completed treatment for malignant neoplasm Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm Z12.4 Encounter for screening for malignant neoplasm of cervix Please see all available options. Concept has been altered. V70.0: Routine general medical examination at a health care facility V72.31: Routine gynecological examination V72.32: Encounter for Papanicolaou cervical smear to confirm findings of recent normal smear following initial abnormal smear Z Encounter for gynecological examination (general) (routine) with abnormal findings Z Encounter for gynecological examination (general) (routine) without abnormal findings Z00.00 Encounter for general adult medical examination without abnormal findings Z00.01 Encounter for general adult medical examination with abnormal findings Z Encounter for gynecological examination (general) (routine) with abnormal findings Z Encounter for gynecological examination (general) (routine) without abnormal findings Z01.42 Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear Use this code if pap smear is a part of a routine gynecological examination. Use this code if pap smear is a part of a routine gynecological examination. Added concept of whether abnormal findings are present. Use additional code(s) to identify abnormal findings when present. Added concept of whether abnormal findings are present. Use additional code(s) to identify abnormal findings when present.
2 V73.81: Screening for Human papillomavirus [HPV] Z11.51 Encounter for screening for human papillomavirus (HPV) V76.10: Screening for malignant neoplasm of V76.11: Screening mammogram for highrisk patient Z12.39 Encounter for other screening for malignant neoplasm of Z12.31 Encounter for screening mammogram for malignant neoplasm of Z12.31 Encounter for screening mammogram for malignant neoplasm of V76.12: Other screening mammogram Z12.31 Encounter for screening mammogram for malignant neoplasm of V76.19: Other screening examination Z12.39 Encounter for other screening for malignant neoplasm of V76.2: Screening for malignant neoplasm of the cervix V76.47: Screening for malignant neoplasm of the vagina V88.01: Acquired absence of both cervix and uterus V88.02: Acquired absence of uterus with remaining cervical stump V88.03:Acquired absence of cervix with remaining uterus : Abnormal mammogram, unspecified If type of screening is mammogram, Z12.31 should be used. Screening code no longer specifies whether the patient is high risk in ICD-10. If a personal or family history of neoplasm exists, it should be coded additionally with the appropriate history code. This code should only be used if the condition being screened for is malignancy. Z12.4 Encounter for screening for malignant neoplasm of cervix When pap smear is a part of a routine gynecological examination, use codes Z or Z Z12.72 Encounter for screening for malignant neoplasm of vagina Z Acquired absence of both cervix and uterus Z Acquired absence of uterus with remaining cervical stump Z Acquired absence of cervix with remaining uterus R92.8 Other abnormal and inconclusive findings on diagnostic imaging of R92.2 Inconclusive mammogram : Mammographic microcalcification 610.0: Solitary cyst of R92.0 Mammographic microcalcification found on diagnostic imaging of R92.1 Mammographic calcification found on diagnostic imaging of N60.01 Solitary cyst of right Laterality has been added. Calcifications on mammogram should be specified as microcalcifications to report code R92.0. A unique code now exists for 'calcifications' found on mammogram. N60.02 Solitary cyst of left
3 611.0: Inflammatory disease of N61 Inflammatory disorders of Includes: abscess of areola, abscess of, mastitis, infective mastitis, carbuncle of : Lump or mass in N63 Unspecified lump in Includes: nodule(s) in NOS : Dysplasia of cervix, unspecified N87.9 Dysplasia of cervix uteri, unspecified For most appropriate code selection, the severity of cervical dysplasia should be specified : Mild dysplasia of cervix N87.0 Mild cervical dysplasia Cervical intraepithelial neoplasia I : Moderate dysplasia of cervix N87.1 Moderate cervical dysplasia Cervical intraepithelial neoplasia II 622.2: Leukoplakia of cervix (uteri) N88.0 Leukoplakia of cervix uteri 623.0: Dysplasia of vagina N89.0 Mild vaginal dysplasia Levels of severity may be captured in code selection in ICD- 10. N89.1 Moderate vaginal dysplasia N89.3 Dysplasia of vagina, unspecified 626.6: Metrorrhagia N92.1 Excessive and frequent menstruation with irregular cycle 627.1: Postmenopausal bleeding N95.0 Postmenopausal bleeding : Unsatisfactory cervical cytology smear 785.6: Enlargement of lymph nodes R Unsatisfactory cytologic smear of cervix R59.0 Localized enlarged lymph nodes : Abnormal glandular Papanicolaou smear of cervix R59.1 Generalized enlarged lymph nodes R59.9 Enlarged lymph nodes, unspecified R Unspecified abnormal cytological findings in specimens from cervix uteri R Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US) R Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H) R Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL) R High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL) R Cytologic evidence of malignancy on smear of cervix If abnormal findings may be specified as one of the below listed codes, a higher level specificity code should be selected. R Other abnormal cytological findings on specimens from cervix uteri
4 174.9: Malignant neoplasm of (female), unspecified C Malignant neoplasm of nipple and areola, right female Concept of laterality has been added. Unspecified laterality option excluded by definition reflects an unspecified site: question appropriateness of this code reported at such high rates. C Malignant neoplasm of nipple and areola, left female C Malignant neoplasm of central portion of right female C Malignant neoplasm of central portion of left female C Malignant neoplasm of upper-inner quadrant of right female C Malignant neoplasm of upper-inner quadrant of left female C Malignant neoplasm of lower-inner quadrant of right female C Malignant neoplasm of lower-inner quadrant of left female C Malignant neoplasm of upper-outer quadrant of right female C Malignant neoplasm of upper-outer quadrant of left female C Malignant neoplasm of lower-outer quadrant of right female C Malignant neoplasm of lower-outer quadrant of left female C Malignant neoplasm of axillary tail of right female C Malignant neoplasm of axillary tail of left female C Malignant neoplasm of overlapping sites of right female C Malignant neoplasm of overlapping sites of left female C Malignant neoplasm of unspecified site of right female C Malignant neoplasm of unspecified site of left female 180.9: Malignant neoplasm of Cervix uteri, unspecified C53.9 Malignant neoplasm of cervix uteri, unspecified Site should be specified to highest extent possible. C53.0 Malignant neoplasm of endocervix C53.1 Malignant neoplasm of exocervix
5 C53.8 Malignant neoplasm of overlapping sites of cervix uteri
BCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
Schedule of Fees for Covered Services
Schedule of s for Covered Services Based on Medicare Part B Rates and effective January 1, 2019 Ladies First is a federally funded program that can pay for breast and cervical cancer screenings and diagnostics.
CMS Limitations Guide Mammography & Bone Mass Measurement
Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations guide provides you with the latest changes.
Women s Imaging ICD-10-CM
Women s Imaging ICD-10-CM Clinical Documentation Guides Brought to you by www.codingstrategies.com The Resource for Physician and Outpatient Coding, Compliance & ICD-10-CM OTHER CLINICAL DOCUMENTATION
Understanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
Sponsored by: INOVA August 19, Presented by: Teri Romano, RN, MBA, CPC, CMDP CONNECT WITH US AT
Sponsored by: INOVA August 19, 2015 Presented by: Teri Romano, RN, MBA, CPC, CMDP CONNECT WITH US AT WWW.KARENZUPKO.COM 2 1 FOCUS Documentation! Diagnosis codes that get paid. Diagnosis codes that accurately
ICD-10-CM Practical Guidance for Pathologists and Labs
LMU Webinar Series ICD-10-CM Practical Guidance for Pathologists and Labs A joint collaboration between March 26, 2015 Key Note Speakers: Dennis L. Padget, MBA, CPA, FHFMA and Brenda Cox, MT(ASCP), CPC,
DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY
Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy
Clinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary
What is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
NON-RECOMMENDED CERVICAL CANCER SCREENING IN ADOLESCENT FEMALES. HEDIS (Administrative)
NON-RECOMMENDED CERVICAL CANCER SCREENING IN ADOLESCENT FEMALES APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE What screening should not be
CEA (CARCINOEMBRYONIC ANTIGEN)
(CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
Breast Carcinoma The Hard Way
Women s Health Breast Carcinoma The Hard Way C50 - Malignant neoplasm of breast C50.0 Malignant neoplasm of nipple and areola C50.01 - Malignant neoplasm of nipple and areola, female C50.011 - Malignant
Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018
Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:
Case Study 1. Cervical Cancer Screening and Sexually Transmitted Infections Case Studies
Case Study 1 Cervical Cancer Screening and Sexually Transmitted Infections Case Studies Joyce, a 32 year old returning veteran, comes in for a Well Woman visit. She has a history of an abnormal Pap before
What is cervical cancer?
What is cervical cancer? The cervix is the bottom part, or neck, of the uterus. Cervical cancer happens when normal cells in the cervix change into abnormal cells, and grow out of control. Most women whose
BC Cancer Cervix Screening 2015 Program Results. February 2018
BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...
Becoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
Methods of Obstetrics & Gynecology treatment
Methods of Obstetrics & Gynecology treatment Gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus and ovaries) and the breasts Lector: MD Ganna
HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
Chapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION
HPV Vaccine FAST FACTS: Payer & Reimbursement Strategies Medicaid: Many state Medicaid programs cover the HPV vaccine, though this coverage varies by state. Information on coverage can be found through
Chapter 28. Breasts and Mammary Glands
Chapter 28 Breasts and Mammary Glands Breasts and Mammary Glands breast mound of tissue overlying the pectoralis major enlarges at puberty and remains so for life most of the time it contains very little
1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs CMS FACT SHEET FOR IMMEDIATE RELEASE Contact:
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???
Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the
Introduction to Colposcopy
Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification
Understanding My Pap Test Results
Form: D-8766 Understanding My Pap Test Results For patients of the Gynecology Oncology Clinic Read this pamphlet to learn more about: why you are having a Pap test how to understand your test results what
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
Cytology and Surgical Pathology of Gynecologic Neoplasms
Cytology and Surgical Pathology of Gynecologic Neoplasms Current Clinical Pathology ANTONIO GIORDANO, MD, PHD SERIES EDITOR For further titles published in this series, go to http://www.springer.com/springer/series/7632
BREAST PATHOLOGY MCQS
BREAST PATHOLOGY MCQS 1) :The most important factor in breast enlargement during pregnancy is A. stromal edema B. secretion of chorionic gonadotropin C. glandular hyperplasia D. proliferation of stroma
The Gynecological Exam. Pelvic Exams and Cervical Cancer Screening. Learning Objectives. Focused History
The Gynecological Exam Components of the exam vary by age and lifestyle: Pelvic Exams and Cervical Cancer Screening 1. Focused history 2. Physical exam Pelvic exam 3. Screening Pap smear for cervical cancer
ICD-10 Common Codes. ICD-10 Code. ICD-10 Code. Diagnoses. Diagnoses
Common s A63.8 Transmitted Diseases A64 A69.20 B00.9 B17.10 Acute Hepatitis C Without Hepatic Coma B18.1 Chronic Viral Hepatitis B Without Delta-Agent B18.2 Chronic Viral Hepatitis C B19.20 Coma B20 B34.9
2015 Gastroenterology Survival Guide
2015 Gastroenterology Survival Guide Chapter 11: ICD-9 Coding Your first line of ICD-9 coding is to attach signs or symptoms to your claim, but even after your gastroenterologist performs a diagnostic
The society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
Carcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
HIV and AIDS Related Cancers DR GORDON AMBAYO UHS
HIV and AIDS Related Cancers DR GORDON AMBAYO UHS INTRODUCTION People with HIV/AIDS are at high risk for developing certain cancers, such as: Kaposi's sarcoma, non-hodgkin lymphoma, and cervical cancer.
Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal
Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital
Twenty-first refresher course. Chan Kit Sheung
Twenty-first refresher course Chan Kit Sheung 7-5-2015 Case 1 Case 1, 29y old, G3P2, referred from MCHC Cervical smear on 27-9-2013: LGSIL, defaulted appointment Cervical smear in 12/2014: negative Colposcopy
uterine cancer endometrial cancer
2018 ICD-10-CM Diagnosis Code. Adenocarcinoma of endometrium ; Cancer of the. (mucous membrane that lines the endometrial cavity). ICD-10-CM C54.1 is grouped. Home ICD 9 Codes Endometrial Cancer ICD 9
Female Reproduc.ve System. Kris.ne Kra7s, M.D.
Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Cervical Carcinoma Once the most common cancer in women now not even in top 10. Decrease due
14. Cancer of the Cervix Uteri
KEY FACTS 14. Cancer of the Cervix Uteri ICD-9 180 On average 78 cases of invasive cervical cancer were registered per year. Half of cases occurred under 49 years of age. 2% of female cancers. Higher than
Cervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence
Making Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
Eradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)
Int. J. Life. Sci. Scienti. Res., 2(3): -279-284 (ISSN: 2455-1716) Impact Factor 2.4 MAY-2016 Research Article (Open access) Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears
LOUISIANA MEDICAID PROGRAM ISSUED: 11/25/14 REPLACED: 10/16/14 CHAPTER 48: FAMILY PLANNING TAKE CHARGE PLUS APPENDIX A: DIAGNOSIS CODES PAGE(S) 9
DIAGNOSIS CODES Take Charge Plus offers a limited benefit package of family planning and family planningrelated services which includes professional services, outpatient services, and laboratory/radiology
Management Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
I have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals
PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea
Promoting Cervical Screening Information for Health Professionals. Cervical Cancer
Promoting Cervical Screening Information for Health Professionals Cervical Cancer PapScreen Victoria Cancer Council Victoria 1 Rathdowne St Carlton VIC 3053 Telephone: (03) 635 5147 Fax: (03) 9635 5360
National Cervical Screening Program MBS Item Descriptors
National Cervical Screening Program MBS Item Descriptors Item Item descriptor 73070 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer
Cervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
Female Reproduc.ve System. Kris.ne Kra7s, M.D.
Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Female Reproduc.ve System Outline Cervix Cervical carcinoma Cervical Carcinoma Once the most
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
Alabama Department of Public Health County Health Department Protocol
Alabama Department of Public Health County Health Department Protocol BREAST AND CERVICAL CANCER TABLE OF CONTENTS ABCCEDP Overview and Purpose... 1 Clinical Guidelines... 1 Patient Enrollment... 1 Resource
Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu
Search for: Search Search Abnormal endometrial biopsy icd 10 Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu What is the icd - 10 for abnormal endometrium Abnormal endometrial biopsy icd
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Surgical Treatment of Gynecomastia Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Surgical Treatment of Gynecomastia Professional Institutional Original
Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
Cervical Cancer Prevention Month. January 2011 Morehouse College
Cervical Cancer Prevention Month January 2011 Morehouse College What is Cervical Cancer? Cervical Cancer begins in the cervix (lower part of the womb, called the uterus). Cervical Cancer, at one point,
International Journal of Biological & Medical Research
Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
What is HPV and why is it so important?
Understanding HPV For many years, Pap smears have been the most effective way to tell if a woman is at risk of developing cervical cancer. The Pap smear may also identify a common viral infection called
Prepared By Jocelyn Palao and Layla Faqih
Prepared By Jocelyn Palao and Layla Faqih The structure of the suspected atypical cell should always be compared to the structure of other similar, benign, cells which are present in the smears. The diagnosis
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
Estimated New Cancers Cases 2003
Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz Estimated New Cancers Cases 2003 Images removed due to copyright reasons.
Cervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
Case. Questions Diseases of the Genital System and the Breast
Diseases of the Genital System and the Breast Case 邓红浙江大学医学院病理学系 Pathology for 7yr (DH) 1 hongdeng@zju.edu.cn Pathology for 7yr (DH) 2 A 54-year-old woman notes a 6-month history of progressive vaginal
CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.
CERVIX MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb. CERVIX Most cervical lesions are: Most are Cervicitis. cancers ( common in women worldwide). CERVICITIS Extremely
Colposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
CONFRONTING CERVICAL CANCER
CONFRONTING CERVICAL CANCER Screening Is the Key to Stopping This Killer Katherine L. Adams, RNC, MSN Cervical cancer may not always be a killer of women, yet it s the third-most common cancer in women
CLINICAL MEDICAL POLICY
CLINICAL MEDICAL POLICY Policy Name: Faslodex (fulvestrant) Policy Number: MP-044-MD-DE Responsible Department(s): Medical Management; Clinical Pharmacy Provider Notice Date: 10/01/2017 Original Effective
Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
Reproductive System Disorders
Reproductive System Disorders Overview Male Infertility Benign Prostatic Hypertrophy Prostate Cancer Female Infertility Endometriosis Pelvic Inflammatory Disease Ovarian Cysts Cancer Breast Cervical Uterine
FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2
FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2 77053 Mammary ductogram or galactogram, single duct, Global Fee $59.05 May be billed with 77055, G0206, 77056, G0204, 76641, 76642 Billable
Should Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
Study population The study population comprised women residing in Keelung, northern Taiwan.
Improved early detection of cervical intraepithelial lesions by combination of conventional Pap smear and speculoscopy Yu B K, Kuo B I, Yen M S, Twu N F, Lai C R, Chen P J, Chien P S, Chao K C, Yuan C
EU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
MEDICAL POLICY SUBJECT: MAMMOGRAPHY: COMPUTER- AIDED DETECTION (CAD) POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: MAMMOGRAPHY: COMPUTER- PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
Alabama Breast and Cervical Cancer Early Detection Program (ABCCEDP) County Health Department Protocol
Alabama Breast and Cervical Cancer Early Detection Program (ABCCEDP) County Health Department Protocol BREAST AND CERVICAL CANCER TABLE OF CONTENTS ABCCEDP Overview and Purpose... 1 Clinical Guidelines...
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
Services can be paid by BCHC only for breast and/or cervical cancer screening and diagnosis. BCHC does not require preauthorization. OFFICE VISITS New Patient - Office Visit (0 minutes face to face) 9920
We re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015
VOLUME 19 ISSUE 1 January 2015 We re on the Web! Visit us at www.kumc.edu/kcr January is National Cervical Cancer Screening Month. Cervical cancer begins in the lining of the cervix (organ connecting the
ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION
Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science